Anbc, Inc. (SYUP) Research

Shanghai Yutong Pharma, Inc., a company based in Shanghai, China, specializes in the development, manufacturing, and distribution of both traditional Chinese herbal remedies and cutting-edge biological pharmaceuticals within the People's Republic of China. Their diverse product portfolio addresses a wide range of health concerns. Noteworthy offerings include Qilisheng, crafted to strengthen the immune system and promote overall vitality. Oral solutions such as Qi-ju-di-huang are formulated to support kidney and liver function, while Qing-re-jie-du serves to reduce fever and alleviate heat. Sheng-mai-yin is designed to conserve vital energy and replenish bodily fluids, and Xiao-qing-long provides relief from coughs and difficulty breathing. The company also produces various syrups: Shen-bao targets the treatment of impotence and spermatorrhoea; Ban-xia offers cough suppression; and Gan-mao-zhi-ke combats symptoms of the flu, coughs, and nasal congestion. Further herbal preparations encompass Ban-lan-gen for common cold and influenza relief; Gan-mao-qing-re, which helps to mitigate minor body aches, pains, and fever; Huang-dan-yin-chen, utilized in managing jaundice and infectious hepatitis; and Liu-shen-qu, prescribed for instances of vomiting and dysentery. These pharmaceutical goods are supplied to distributors via a wholesale model.

Market snapshot

Symbol
SYUP
Price
$0.00
Day change
0.00%
Market cap
$15.9K
P/E ratio
0.01x
52-week range
0.0001-0.005
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • BZAM Ltd. (BZAMF)
  • CanaQuest Medical Corp. (CANQF)
  • Cotinga Pharmaceuticals Inc. (COTQF)
  • ETAO International Co., Ltd. (ETAOF)
  • ForU Holdings, Inc. (FORU)
  • Genex Pharmaceutical, Inc. (GENX)
  • Greenwind Holdings Inc. (NEWG)
  • NxGen Brands Inc. (NXGB)

Open Anbc, Inc. (SYUP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.